Code | 4651C | ||||||||||
MA number | 41/0205/17-S | ||||||||||
Product Form: | tbl flm 14x5 mg (blis.PA/Al/PVC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Laboratorios Liconsa, S.A., Spain | ||||||||||
Therapeutic Class: | 41 - CARDIACA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister PA/Al/PVC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 17.07.2017 |
SPC: | SPC_Ivabradín Liconsa filmom obalené tablety_02_2022.pdf |
PIL: | PIL_Ivabradín Liconsa_tbl flm_05_2022.pdf |
Safety feature | Yes |
Data update: | 25.02.2022 |